Cargando…

Association of reduced heme oxygenase-1 with excessive Toll-like receptor 4 expression in peripheral blood mononuclear cells in Behçet's disease

INTRODUCTION: Toll-like receptors (TLRs) mediate signaling that triggers activation of the innate immune system, whereas heme oxygenase (HO)-1 (an inducible heme-degrading enzyme that is induced by various stresses) suppresses inflammatory responses. We investigated the interaction between TLR and H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kirino, Yohei, Takeno, Mitsuhiro, Watanabe, Reikou, Murakami, Shuji, Kobayashi, Masayoshi, Ideguchi, Haruko, Ihata, Atsushi, Ohno, Shigeru, Ueda, Atsuhisa, Mizuki, Nobuhisa, Ishigatsubo, Yoshiaki
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374472/ https://www.ncbi.nlm.nih.gov/pubmed/18234118 http://dx.doi.org/10.1186/ar2367

Ejemplares similares

Adalimumab in the management of Behçet’s disease
por: Ueda, Atsuhisa, et al.
Publicado: (2015)

Continuous evolution of clinical phenotype in 578 Japanese patients with Behçet’s disease: a retrospective observational study
por: Kirino, Yohei, et al.
Publicado: (2016)

Development of anti-infliximab antibody is associated with reduced efficacy and infusion reaction in Behçet's disease with uveitis
por: Ishigatsubo, Y, et al.
Publicado: (2015)

Changes in the proportion of clinical clusters contribute to the phenotypic evolution of Behçet’s disease in Japan
por: Soejima, Yutaro, et al.
Publicado: (2021)

Clinical Course before and after Cataract and Glaucoma Surgery under Systemic Infliximab Therapy in Patients with Behçet's Disease
por: Nishida, Tomomi, et al.
Publicado: (2011)

Power Doppler ultrasonography is useful for assessing disease activity and predicting joint destruction in rheumatoid arthritis patients receiving tocilizumab—preliminary data
por: Hama, Maasa, et al.
Publicado: (2011)

Increased serum HO-1 in hemophagocytic syndrome and adult-onset Still's disease: use in the differential diagnosis of hyperferritinemia
por: Kirino, Yohei, et al.
Publicado: (2005)

Distinct clinical features between acute and chronic progressive parenchymal neuro-Behçet disease: meta-analysis
por: Ishido, Mizuho, et al.
Publicado: (2017)

Functional analysis of macrophages in Behçet's disease
por: Nakano, H, et al.
Publicado: (2015)

Recommendations for the Management of Neuro-Behçet's Disease by the Japanese National Research Committee for Behçet's Disease
por: Hirohata, Shunsei, et al.
Publicado: (2020)

Clinical characteristics of neuro-Behcet’s disease in Japan: a multicenter retrospective analysis
por: Hirohata, Shunsei, et al.
Publicado: (2011)

Bone erosions in rheumatoid arthritis can be repaired through reduction in disease activity with conventional disease-modifying antirheumatic drugs
por: Ideguchi, Haruko, et al.
Publicado: (2006)

Genome-wide association analysis identifies new susceptibility loci for Behçet's disease and epistasis between HLA-B*51 and ERAP1
por: Kirino, Yohei, et al.
Publicado: (2013)

Immune Reactions in Behçet's Disease
por: Kaneko, Fumio, et al.
Publicado: (2014)

PW03-014 - TLR4 and MEFV variants are Behçet's risk factors
por: Kirino, Y, et al.
Publicado: (2013)

Armadillo Repeat Containing 8α Binds to HRS and Promotes HRS Interaction with Ubiquitinated Proteins
por: Tomaru, Koji, et al.
Publicado: (2010)

Dysregulated heme oxygenase-1(low) M2-like macrophages augment lupus nephritis via Bach1 induced by type I interferons
por: Kishimoto, Daiga, et al.
Publicado: (2018)

Dense genotyping of immune-related loci implicates host responses to microbial exposure in Behçet’s disease susceptibility
por: Takeuchi, Masaki, et al.
Publicado: (2017)

PW03-011 – New Behçet's loci and gene-gene interactions
por: Remmers, EF, et al.
Publicado: (2013)

The association of Behçet's syndrome with HLA-B51 as understood in 2021
por: Takeno, Mitsuhiro
Publicado: (2022)

Heme Oxygenase-1 Deficiency
por: Renji, Soumya, et al.
Publicado: (2021)

PW03-013 - Behçet's disease: genotype-phenotype correlations
por: Takeuchi, M, et al.
Publicado: (2013)

Role of Heme Oxygenase as a Modulator of Heme-Mediated Pathways
por: Duvigneau, J. Catharina, et al.
Publicado: (2019)

Heme-heme oxygenase-2 reduces the atherosclerosis by preventing inflammation
por: Wang, Zhenzhen, et al.
Publicado: (2022)

The predictive prognostic factors for polymyositis/dermatomyositis-associated interstitial lung disease
por: Sugiyama, Yumiko, et al.
Publicado: (2018)

Peroxynitrite-mediated inactivation of heme oxygenases
por: Kinobe, Robert, et al.
Publicado: (2004)

Heme oxygenase 1 regulates osteoclastogenesis
por: Zwerina, J, et al.
Publicado: (2005)

Curcumin and Heme Oxygenase: Neuroprotection and Beyond
por: Mhillaj, Emanuela, et al.
Publicado: (2019)

The non-canonical functions of the heme oxygenases
por: Vanella, Luca, et al.
Publicado: (2016)

Clinical and Pathological Roles of Ro/SSA Autoantibody System
por: Yoshimi, Ryusuke, et al.
Publicado: (2012)

Comprehensive analysis of the association between UBAC2 polymorphisms and Behçet’s disease in a Japanese population
por: Yamazoe, Kyoko, et al.
Publicado: (2017)

Integrative Survival Response Evoked by Heme Oxygenase-1 and Heme Metabolites
por: Pae, Hyun-Ock, et al.
Publicado: (2008)

How Heme Oxygenase-1 Prevents Heme-Induced Cell Death
por: Lanceta, Lilibeth, et al.
Publicado: (2015)

A noncanonical heme oxygenase specific for the degradation of c-type heme
por: Li, Shuxin, et al.
Publicado: (2021)

Heme, Heme Oxygenase-1, Statins, and SARS-CoV-2
por: Stevenson, David K., et al.
Publicado: (2023)

GWAS-identified CCR1 and IL10 loci contribute to M1 macrophage-predominant inflammation in Behçet’s disease
por: Nakano, Hiroto, et al.
Publicado: (2018)

Therapeutic Roles of Heme Oxygenase-1 in Metabolic Diseases: Curcumin and Resveratrol Analogues as Possible Inducers of Heme Oxygenase-1
por: Son, Yong, et al.
Publicado: (2013)

Heme Oxygenase-1, Oxidation, Inflammation, and Atherosclerosis
por: Araujo, Jesus A., et al.
Publicado: (2012)

The Expression of Heme Oxygenase-1 Induced by Lansoprazole
por: Takagi, Tomohisa, et al.
Publicado: (2009)

Pharmacological Targeting of Heme Oxygenase-1 in Osteoarthritis
por: Sanada, Yohei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0klpgjha6f8ilim8623ts822no